|
2024-06-25 |
2024-06-24 |
V
Verkauf
|
Aranda Richard
Chief Medical Officer
Führungsperson
|
1.908
-1.0%
0,66
1.260 USD
|
1.908
-1.0%
|
0,66
|
1.260 USD
|
|
|
2024-06-24 |
2024-06-21 |
K
Kauf
|
Hasnain Faheem
President & CEO
Geschäftsführender Verwaltungsratsmitglied
|
372.000
+7.4%
0,67
250.282 USD
|
372.000
+7.4%
|
0,67
|
250.282 USD
|
|
|
2024-06-20 |
2024-06-18 |
K
Kauf
|
Giraudo Bryan
COO/CFO
Führungsperson
|
100.000
+26.3%
0,59
59.110 USD
|
100.000
+26.3%
|
0,59
|
59.110 USD
|
|
|
2024-06-20 |
2024-06-17 |
K
Kauf
|
Smith Robert Paul JR
Chief Commercial Officer
Führungsperson
|
25.000
+inf%
0,60
15.050 USD
|
25.000
+inf%
|
0,60
|
15.050 USD
|
|
|
2024-03-28 |
2024-03-27 |
V
Verkauf
|
Hasnain Faheem
President & CEO
Geschäftsführender Verwaltungsratsmitglied
|
23.172
-16.2%
1,16
26.773 USD
|
23.172
-16.2%
|
1,16
|
26.773 USD
|
|
|
2024-03-28 |
2024-03-27 |
V
Verkauf
|
Christian Waage
EVP, Tech Ops and Admin
Führungsperson
|
6.430
-1.1%
1,16
7.430 USD
|
6.430
-1.1%
|
1,16
|
7.430 USD
|
|
|
2024-03-28 |
2024-03-27 |
V
Verkauf
|
Giraudo Bryan
COO/CFO
Führungsperson
|
6.430
-6.5%
1,16
7.431 USD
|
6.430
-6.5%
|
1,16
|
7.431 USD
|
|
|
2024-03-19 |
2024-03-18 |
V
Verkauf
|
Peterson Caryn
EVP, Regulatory Affairs
Führungsperson
|
4.018
-7.5%
1,33
5.343 USD
|
4.018
-7.5%
|
1,33
|
5.343 USD
|
|
|
2024-03-19 |
2024-03-18 |
V
Verkauf
|
Aranda Richard
Chief Medical Officer
Führungsperson
|
4.018
-2.0%
1,33
5.342 USD
|
4.018
-2.0%
|
1,33
|
5.342 USD
|
|
|
2023-11-17 |
2023-11-15 |
K
Kauf
|
Milligan Sandra
Nicht geschäftsführender Verwaltungsratsmitglied
|
32.000
+inf%
0,79
25.213 USD
|
32.000
+inf%
|
0,79
|
25.213 USD
|
|
|
2023-11-14 |
2023-11-13 |
K
Kauf
|
Giraudo Bryan
COO/CFO
Führungsperson
|
200.000
+111.1%
0,56
112.880 USD
|
200.000
+111.1%
|
0,56
|
112.880 USD
|
|
|
2023-06-26 |
2023-06-22 |
V
Verkauf
|
Aranda Richard
Chief Medical Officer
Führungsperson
|
1.814
-0.9%
1,29
2.340 USD
|
1.814
-0.9%
|
1,29
|
2.340 USD
|
|
|
2023-04-05 |
2023-04-04 |
K
Kauf
|
Giraudo Bryan
COO/CFO
Führungsperson
|
55.000
+77.5%
1,02
56.095 USD
|
55.000
+77.5%
|
1,02
|
56.095 USD
|
|
|
2023-03-22 |
2023-03-22 |
K
Kauf
|
Hasnain Faheem
President & CEO
Geschäftsführender Verwaltungsratsmitglied
|
440.500
+10.9%
1,14
503.580 USD
|
440.500
+10.9%
|
1,14
|
503.580 USD
|
|
|
2023-03-22 |
2023-03-21 |
K
Kauf
|
Hasnain Faheem
President & CEO
Geschäftsführender Verwaltungsratsmitglied
|
269.389
+7.1%
1,20
322.324 USD
|
269.389
+7.1%
|
1,20
|
322.324 USD
|
|
|
2023-03-22 |
2023-03-20 |
K
Kauf
|
Giraudo Bryan
COO/CFO
Führungsperson
|
50.000
+238.2%
0,97
48.435 USD
|
50.000
+238.2%
|
0,97
|
48.435 USD
|
|
|
2023-03-22 |
2023-03-20 |
K
Kauf
|
Hasnain Faheem
President & CEO
Geschäftsführender Verwaltungsratsmitglied
|
168.683
+4.7%
1,03
174.486 USD
|
168.683
+4.7%
|
1,03
|
174.486 USD
|
|
|
2023-03-22 |
2023-03-20 |
K
Kauf
|
Christian Waage
EVP, Tech Ops and Admin
Führungsperson
|
18.500
+133.2%
1,20
22.145 USD
|
18.500
+133.2%
|
1,20
|
22.145 USD
|
|
|
2023-03-20 |
2023-03-16 |
V
Verkauf
|
Carter Laura
Chief Scientific Officer
Führungsperson
|
6.029
-7.3%
1,10
6.620 USD
|
6.029
-7.3%
|
1,10
|
6.620 USD
|
|
|
2023-03-20 |
2023-03-16 |
V
Verkauf
|
Peterson Caryn
EVP, Regulatory Affairs
Führungsperson
|
7.564
-12.3%
1,10
8.305 USD
|
7.564
-12.3%
|
1,10
|
8.305 USD
|
|
|
2023-03-20 |
2023-03-16 |
V
Verkauf
|
Aranda Richard
Chief Medical Officer
Führungsperson
|
7.563
-3.7%
1,10
8.304 USD
|
7.563
-3.7%
|
1,10
|
8.304 USD
|
|
|
2022-10-25 |
2022-10-24 |
V
Verkauf
|
Carter Laura
Chief Scientific Officer
Führungsperson
|
4.876
-5.6%
12,07
58.868 USD
|
4.876
-5.6%
|
12,07
|
58.868 USD
|
|
|
2022-10-25 |
2022-10-24 |
V
Verkauf
|
Aranda Richard
Chief Medical Officer
Führungsperson
|
4.757
-2.3%
12,07
57.431 USD
|
4.757
-2.3%
|
12,07
|
57.431 USD
|
|
|
2022-10-25 |
2022-10-24 |
V
Verkauf
|
Peterson Caryn
EVP, Regulatory Affairs
Führungsperson
|
4.757
-7.2%
12,07
57.431 USD
|
4.757
-7.2%
|
12,07
|
57.431 USD
|
|
|
2022-07-15 |
2022-07-15 |
K
Kauf
|
Giraudo Bryan
COO/CFO
Führungsperson
|
13.869
+194.8%
7,21
99.995 USD
|
13.869
+194.8%
|
7,21
|
99.995 USD
|
|
|
2022-07-15 |
2022-07-15 |
K
Kauf
|
Christian Waage
EVP, Tech Ops and Admin
Führungsperson
|
6.934
+99.7%
7,21
49.994 USD
|
6.934
+99.7%
|
7,21
|
49.994 USD
|
|
|
2022-07-15 |
2022-07-15 |
K
Kauf
|
Hasnain Faheem
President & CEO
Geschäftsführender Verwaltungsratsmitglied
|
138.696
+4.0%
7,21
999.998 USD
|
138.696
+4.0%
|
7,21
|
999.998 USD
|
|
|
2022-07-15 |
2022-07-15 |
K
Kauf
|
Carter Laura
Chief Scientific Officer
Führungsperson
|
6.934
+8.6%
7,21
49.994 USD
|
6.934
+8.6%
|
7,21
|
49.994 USD
|
|
|
2022-07-05 |
2022-07-01 |
V
Verkauf
|
Carter Laura
Chief Scientific Officer
Führungsperson
|
8.808
-9.9%
8,25
72.648 USD
|
8.808
-9.9%
|
8,25
|
72.648 USD
|
|
|
2022-06-23 |
2022-06-22 |
V
Verkauf
|
Aranda Richard
Chief Medical Officer
Führungsperson
|
1.778
-0.8%
6,88
12.233 USD
|
1.778
-0.8%
|
6,88
|
12.233 USD
|
|
|
2022-05-05 |
2022-05-04 |
V
Verkauf
|
Carter Laura
Chief Scientific Officer
Führungsperson
|
1.262
-1.4%
7,20
9.086 USD
|
1.262
-1.4%
|
7,20
|
9.086 USD
|
|
|
2022-03-24 |
2022-03-23 |
V
Verkauf
|
Hasnain Faheem
President & CEO
Geschäftsführender Verwaltungsratsmitglied
|
19.035
-11.7%
8,92
169.697 USD
|
19.035
-11.7%
|
8,92
|
169.697 USD
|
|
|
2022-03-24 |
2022-03-23 |
V
Verkauf
|
Giraudo Bryan
COO/CFO
Führungsperson
|
10.722
-9.8%
8,92
95.587 USD
|
10.722
-9.8%
|
8,92
|
95.587 USD
|
|
|
2022-03-24 |
2022-03-23 |
V
Verkauf
|
Christian Waage
EVP, Tech Ops and Admin
Führungsperson
|
10.722
-1.8%
8,92
95.587 USD
|
10.722
-1.8%
|
8,92
|
95.587 USD
|
|
|
2022-03-17 |
2022-03-16 |
V
Verkauf
|
Peterson Caryn
EVP, Regulatory Affairs
Führungsperson
|
6.279
-8.7%
8,28
51.978 USD
|
6.279
-8.7%
|
8,28
|
51.978 USD
|
|
|
2022-03-17 |
2022-03-16 |
V
Verkauf
|
Carter Laura
Chief Scientific Officer
Führungsperson
|
5.002
-5.2%
8,28
41.407 USD
|
5.002
-5.2%
|
8,28
|
41.407 USD
|
|
|
2022-03-17 |
2022-03-16 |
V
Verkauf
|
Aranda Richard
Chief Medical Officer
Führungsperson
|
6.278
-2.9%
8,28
51.976 USD
|
6.278
-2.9%
|
8,28
|
51.976 USD
|
|
|
2021-10-26 |
2021-10-25 |
V
Verkauf
|
Aranda Richard
Chief Medical Officer
Führungsperson
|
2.377
-1.1%
12,25
29.118 USD
|
2.377
-1.1%
|
12,25
|
29.118 USD
|
|
|
2021-10-26 |
2021-10-25 |
V
Verkauf
|
Peterson Caryn
EVP, Regulatory Affairs
Führungsperson
|
2.377
-3.2%
12,25
29.118 USD
|
2.377
-3.2%
|
12,25
|
29.118 USD
|
|
|
2021-10-26 |
2021-10-25 |
V
Verkauf
|
Carter Laura
Chief Scientific Officer
Führungsperson
|
2.377
-2.4%
12,25
29.118 USD
|
2.377
-2.4%
|
12,25
|
29.118 USD
|
|
|
2021-03-25 |
2021-03-23 |
V
Verkauf
|
Salter-Cid Luisa
Chief Scientific Officer
Führungsperson
|
5.491
-2.6%
9,48
52.052 USD
|
5.491
-2.6%
|
9,48
|
52.052 USD
|
|
|
2021-03-25 |
2021-03-23 |
V
Verkauf
|
Giraudo Bryan
Chief Financial Officer
Führungsperson
|
5.490
-4.8%
9,48
52.046 USD
|
5.490
-4.8%
|
9,48
|
52.046 USD
|
|
|
2021-03-25 |
2021-03-23 |
V
Verkauf
|
Christian Waage
EVP & General Counsel
Führungsperson
|
5.490
-0.9%
9,48
52.051 USD
|
5.490
-0.9%
|
9,48
|
52.051 USD
|
|
|
2020-10-14 |
2020-10-14 |
K
Kauf
|
Giraudo Bryan
Chief Financial Officer
Führungsperson
|
3.000
+72.8%
10,01
30.036 USD
|
3.000
+72.8%
|
10,01
|
30.036 USD
|
|
|
2020-10-14 |
2020-10-14 |
K
Kauf
|
Hasnain Faheem
Nicht geschäftsführender Verwaltungsratsmitglied
|
96.520
+2.9%
10,36
999.995 USD
|
96.520
+2.9%
|
10,36
|
999.995 USD
|
|
|
2020-10-14 |
2020-10-14 |
K
Kauf
|
Christian Waage
EVP & General Counsel
Führungsperson
|
2.500
+56.1%
9,53
23.818 USD
|
2.500
+56.1%
|
9,53
|
23.818 USD
|
|
|
2020-06-23 |
2020-06-23 |
K
Kauf
|
Giraudo Bryan
Chief Financial Officer
Führungsperson
|
2.000
+94.3%
12,96
25.922 USD
|
2.000
+94.3%
|
12,96
|
25.922 USD
|
|
|
2019-12-31 |
2019-12-30 |
V
Verkauf
|
Dupont Jakob
Chief Medical Officer
Führungsperson
|
40.000
-100.0%
15,00
600.004 USD
|
40.000
-100.0%
|
15,00
|
600.004 USD
|
|
|
2019-12-31 |
2019-12-27 |
V
Verkauf
|
Dupont Jakob
Chief Medical Officer
Führungsperson
|
1.994
-100.0%
15,81
31.534 USD
|
1.994
-100.0%
|
15,81
|
31.534 USD
|
|
|
2019-09-27 |
2019-09-27 |
K
Kauf
|
Christian Waage
EVP & General Counsel
|
1.000
+29.0%
16,65
16.654 USD
|
1.000
+29.0%
|
16,65
|
16.654 USD
|
|
|
2019-09-27 |
2019-09-27 |
K
Kauf
|
Gujrathi Sheila
President & CEO
Geschäftsführender Verwaltungsratsmitglied
|
10.000
+0.2%
16,80
167.980 USD
|
10.000
+0.2%
|
16,80
|
167.980 USD
|
|
|
2019-09-27 |
2019-09-27 |
K
Kauf
|
Hasnain Faheem
|
10.000
+0.3%
16,80
167.980 USD
|
10.000
+0.3%
|
16,80
|
167.980 USD
|
|
|
2019-09-26 |
2019-09-26 |
K
Kauf
|
Giraudo Bryan
Chief Financial Officer
|
1.121
+112.1%
16,78
18.810 USD
|
1.121
+112.1%
|
16,78
|
18.810 USD
|
|
|
2019-09-23 |
2019-09-20 |
V
Verkauf
|
Omega Fund V, L.P.
Large shareholder
|
183.607
-2.7%
21,96
4.032.561 USD
|
183.607
-2.7%
|
21,96
|
4.032.561 USD
|
|
|
2019-09-18 |
2019-09-18 |
V
Verkauf
|
Omega Fund V, L.P.
Former director.
Large shareholder
|
45.600
-0.7%
21,88
997.637 USD
|
45.600
-0.7%
|
21,88
|
997.637 USD
|
|
|
2019-09-18 |
2019-09-17 |
V
Verkauf
|
Omega Fund V, L.P.
Former director.
Large shareholder
|
23.400
-0.3%
21,62
505.791 USD
|
23.400
-0.3%
|
21,62
|
505.791 USD
|
|
|
2019-09-18 |
2019-09-16 |
V
Verkauf
|
Omega Fund V, L.P.
Former director.
Large shareholder
|
13.213
-0.2%
21,52
284.331 USD
|
13.213
-0.2%
|
21,52
|
284.331 USD
|
|
|
2019-09-12 |
2019-09-11 |
V
Verkauf
|
Omega Fund V, L.P.
Large shareholder
|
80.403
-1.2%
21,31
1.713.629 USD
|
80.403
-1.2%
|
21,31
|
1.713.629 USD
|
|
|
2019-09-12 |
2019-09-10 |
V
Verkauf
|
Omega Fund V, L.P.
Large shareholder
|
32.373
-0.5%
21,00
679.865 USD
|
32.373
-0.5%
|
21,00
|
679.865 USD
|
|
|
2019-09-09 |
2019-09-06 |
V
Verkauf
|
Omega Fund V, L.P.
Large shareholder
|
8.700
-0.1%
21,51
187.103 USD
|
8.700
-0.1%
|
21,51
|
187.103 USD
|
|
|
2019-09-09 |
2019-09-05 |
V
Verkauf
|
Omega Fund V, L.P.
Large shareholder
|
12.704
-0.2%
21,60
274.434 USD
|
12.704
-0.2%
|
21,60
|
274.434 USD
|
|
|
2019-08-29 |
2019-08-29 |
V
Verkauf
|
Salter-Cid Luisa
Chief Scientific Officer
Führungsperson
|
26.252
-17.5%
20,09
527.319 USD
|
26.252
-17.5%
|
20,09
|
527.319 USD
|
|
|
2019-08-29 |
2019-08-28 |
V
Verkauf
|
Salter-Cid Luisa
Chief Scientific Officer
Führungsperson
|
23.748
-13.6%
19,65
466.724 USD
|
23.748
-13.6%
|
19,65
|
466.724 USD
|
|
|
2019-06-03 |
2019-05-30 |
K
Kauf
|
Giraudo Bryan
Chief Financial Officer
|
1.000
+inf%
18,70
18.700 USD
|
1.000
+inf%
|
18,70
|
18.700 USD
|
|
|
2019-02-12 |
2019-02-12 |
K
Kauf
|
Christian Waage
EVP & General Counsel
Führungsperson
|
1.550
+0.3%
16,00
24.800 USD
|
1.550
+0.3%
|
16,00
|
24.800 USD
|
|
|
2019-02-12 |
2019-02-12 |
K
Kauf
|
Cox Russell J.
Nicht geschäftsführender Verwaltungsratsmitglied
|
7.200
+inf%
16,00
115.200 USD
|
7.200
+inf%
|
16,00
|
115.200 USD
|
|
|
2019-02-12 |
2019-02-12 |
K
Kauf
|
Giraudo Bryan
Chief Financial Officer
Führungsperson
|
6.000
+33.6%
16,00
96.000 USD
|
6.000
+33.6%
|
16,00
|
96.000 USD
|
|
